October is American Pharmacists Month, and we’ve teamed up with the International Pharmaceutical Federation (FIP) to bring you an interview with Dr. Catherine Duggan, CEO, about how pharmacists and the pharmaceutical industry at large can contribute to the fight against antimicrobial resistance.
“Baselines are used throughout healthcare to evaluate safety, performance, and fiscal execution at the macro and micro level,” writes John Hurst, Pharm D, BCIDP and Senior Director of Antimicrobial Stewardship at bioMérieux.
The COVID-19 pandemic has shown the world how valuable and important infection prevention programs are. In addition to handling routine threats such as flu season and healthcare associated infections, infection prevention and control programs around the world have shifted into overdrive to fight the pandemic and keep communities healthy.
Administering antimicrobial therapy is essential for treating the underlying infections that cause sepsis, but the protocols for doing so can, at times, clash with antimicrobial stewardship guidelines.